Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 23,873 | 22,597 | 18,280 | 19,140 | 21,360 |
| Cost of Goods | 17,757 | 17,421 | 13,666 | 13,760 | 15,279 |
| Gross Profit | 6,116 | 5,176 | 4,614 | 5,379 | 6,081 |
| Operating Expenses | 1,127 | 409 | 1,417 | 1,386 | 1,084 |
| Operating Income | 4,989 | 4,768 | 3,197 | 3,994 | 4,996 |
| Interest Expense | 6 | 40 | 0 | 11 | N/A |
| Other Income | 71 | 284 | -66 | -199 | 70 |
| Pre-tax Income | 5,055 | 5,011 | 3,131 | 3,783 | 5,066 |
| Income Tax | 1,415 | 804 | 885 | 1,150 | 1,418 |
| Net Income Continuous | 3,639 | 3,861 | 2,246 | 2,633 | 3,648 |
| Net Income | $3,639 | $3,861 | $2,246 | $2,633 | $3,648 |
| EPS Basic Total Ops | 0.18 | 0.19 | 0.12 | 0.13 | 0.19 |
| EPS Basic Continuous Ops | 0.18 | 0.19 | 0.12 | 0.13 | 0.19 |
| EPS Diluted Total Ops | 0.18 | 0.19 | 0.12 | 0.13 | 0.19 |
| EPS Diluted Continuous Ops | 0.18 | 0.19 | 0.12 | 0.13 | 0.19 |
| EBITDA(a) | $6,672 | $7,159 | $4,548 | $5,184 | $6,081 |